159 related articles for article (PubMed ID: 6165826)
1. Effect of xylometazoline nasal spray on nasal conductance in subjects with coryza.
Hamilton LH
J Otolaryngol; 1981 Apr; 10(2):109-16. PubMed ID: 6165826
[TBL] [Abstract][Full Text] [Related]
2. The nasal decongestant effect of xylometazoline in the common cold.
Eccles R; Eriksson M; Garreffa S; Chen SC
Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
[TBL] [Abstract][Full Text] [Related]
3. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
Eccles R; Martensson K; Chen SC
Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
[TBL] [Abstract][Full Text] [Related]
4. [Decongestant nasal spray. Results of a rhinomanometric double-blind study].
Maranta CA; Simmen D
Schweiz Med Wochenschr; 1996 Nov; 126(44):1875-80. PubMed ID: 8984600
[TBL] [Abstract][Full Text] [Related]
5. Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and MRI.
Caenen M; Hamels K; Deron P; Clement P
Rhinology; 2005 Sep; 43(3):205-9. PubMed ID: 16218514
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
[TBL] [Abstract][Full Text] [Related]
7. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
[TBL] [Abstract][Full Text] [Related]
8. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
Castellano F; Mautone G
Drugs Exp Clin Res; 2002; 28(1):27-35. PubMed ID: 12073765
[TBL] [Abstract][Full Text] [Related]
9. A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold.
Hagen M; Clark K; Kalita P; Serra G; Sanchez E; Varbiro G; Albasser MM
Ther Adv Respir Dis; 2024; 18():17534666241228927. PubMed ID: 38372128
[TBL] [Abstract][Full Text] [Related]
10. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.
Strandell B; Norgren-Holst E; Tran N; Jakobsen HB; Chen S
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):744-51. PubMed ID: 19954713
[TBL] [Abstract][Full Text] [Related]
11. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
Jessen M; Ivarsson A; Malm L
Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
[TBL] [Abstract][Full Text] [Related]
12. Changes in nasal nitric oxide concentration associated with symptoms of common cold and treatment with a topical nasal decongestant.
Ferguson EA; Eccles R
Acta Otolaryngol; 1997 Jul; 117(4):614-7. PubMed ID: 9288222
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of topical tuaminoheptane combined with N-acetyl-cysteine in reducing nasal resistance. A double-blind rhinomanometric study versus xylometazoline and placebo.
Cogo A; Chieffo A; Farinatti M; Ciaccia A
Arzneimittelforschung; 1996 Apr; 46(4):385-8. PubMed ID: 8740084
[TBL] [Abstract][Full Text] [Related]
14. Does nasal decongestion improve obstructive sleep apnea?
Clarenbach CF; Kohler M; Senn O; Thurnheer R; Bloch KE
J Sleep Res; 2008 Dec; 17(4):444-9. PubMed ID: 18710420
[TBL] [Abstract][Full Text] [Related]
15. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial.
Eby GA; Halcomb WW
Altern Ther Health Med; 2006; 12(1):34-8. PubMed ID: 16454145
[TBL] [Abstract][Full Text] [Related]
16. Treatment with xylometazoline (Otrivin) nosedrops over a six-week period.
Petruson B
Rhinology; 1981 Sep; 19(3):167-72. PubMed ID: 6171024
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection.
Eccles R; Pedersen A; Regberg D; Tulento H; Borum P; Stjärne P
Am J Rhinol; 2007; 21(1):40-5. PubMed ID: 17283559
[TBL] [Abstract][Full Text] [Related]
18. Nasal airflow asymmetry and the effects of a topical nasal decongestant.
Williams RG; Eccles R
Rhinology; 1992 Dec; 30(4):277-82. PubMed ID: 1281924
[TBL] [Abstract][Full Text] [Related]
19. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
Graf P; Juto JE
Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
[TBL] [Abstract][Full Text] [Related]
20. Immediate effect of benzalkonium chloride in decongestant nasal spray on the human nasal mucosal temperature.
Lindemann J; Leiacker R; Wiesmiller K; Rettinger G; Keck T
Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):357-61. PubMed ID: 15270822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
